Nicholas Investment Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Nicholas Investment Partners’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-416,151	Closed	-$19.3M	–	213
2023 Q2	$19.3M	Hold	416,151	–	–	1.32%	25
2023 Q1	$11.9M	Buy	+416,151	New	+$12.3M	0.91%	37
2022 Q4	–	Sell	-97,838	Closed	-$1.98M	–	204
2022 Q3	$1.98M	Buy	+97,838	New	+$1.78M	0.18%	123

Nicholas Investment Partners's DICE Position: Q3 2023 in Review

Nicholas Investment Partners sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 416,151 shares — an estimated $19.3M sold.

Nicholas Investment Partners first reported a position in DICE in Q3 2022 and held it in 3 quarters. The position peaked at $19.3M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Nicholas Investment Partners reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Nicholas Investment Partners sold 416,151 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $19.3M.
Nicholas Investment Partners first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Nicholas Investment Partners's DICE Therapeutics, Inc. Common Stock position peaked at $19.3M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Nicholas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.